
Phi Hoang
Examiner (ID: 1921, Phone: (571)270-3417 , Office: P/2613 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2678, 2619, 2628, 2613, 4178 |
| Total Applications | 1057 |
| Issued Applications | 820 |
| Pending Applications | 71 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19165733
[patent_doc_number] => 11981619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Alkoxylated esteramines and salts thereof
[patent_app_type] => utility
[patent_app_number] => 16/624956
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5871
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624956 | Alkoxylated esteramines and salts thereof | Jun 25, 2018 | Issued |
Array
(
[id] => 15020685
[patent_doc_number] => 20190321347
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2019-10-24
[patent_title] => LIQUID COMPOSITION FOR WASH OF SCALP AND AND HAIR, OR FOR WASH OF SKIN
[patent_app_type] => utility
[patent_app_number] => 16/017782
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017782 | Liquid composition for wash of scalp and and hair, or for wash of skin | Jun 24, 2018 | Issued |
Array
(
[id] => 15020685
[patent_doc_number] => 20190321347
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2019-10-24
[patent_title] => LIQUID COMPOSITION FOR WASH OF SCALP AND AND HAIR, OR FOR WASH OF SKIN
[patent_app_type] => utility
[patent_app_number] => 16/017782
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017782 | Liquid composition for wash of scalp and and hair, or for wash of skin | Jun 24, 2018 | Issued |
Array
(
[id] => 15160601
[patent_doc_number] => 10485773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Benzenesulfonamide derivatives and method for treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/014295
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5002
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014295 | Benzenesulfonamide derivatives and method for treating cancer | Jun 20, 2018 | Issued |
Array
(
[id] => 16512893
[patent_doc_number] => 20200392151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/622967
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622967
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622967 | Combination of a Mcl-1 inhibitor and a standard of care treatment for hematologic cancers, uses and pharmaceutical compositions thereof | Jun 20, 2018 | Issued |
Array
(
[id] => 16236658
[patent_doc_number] => 20200253892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => ANTICANCER AGENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/619206
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619206
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619206 | Anticancer agent and use thereof | Jun 11, 2018 | Issued |
Array
(
[id] => 16548462
[patent_doc_number] => 10881599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Whitening composition including novel kaempferol-based compound derived from post-fermented tea
[patent_app_type] => utility
[patent_app_number] => 16/622120
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622120 | Whitening composition including novel kaempferol-based compound derived from post-fermented tea | Jun 10, 2018 | Issued |
Array
(
[id] => 16086639
[patent_doc_number] => 20200197306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => CATIONIC LIQUID CRYSTALLINE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/620090
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620090 | CATIONIC LIQUID CRYSTALLINE NANOPARTICLES | Jun 6, 2018 | Abandoned |
Array
(
[id] => 13458097
[patent_doc_number] => 20180280591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => CHLORHEXIDINE GLUCONATE COMPOSITIONS, RESIN SYSTEMS AND ARTICLE
[patent_app_type] => utility
[patent_app_number] => 16/002763
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16002763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/002763 | Chlorhexidine gluconate compositions, resin systems and article | Jun 6, 2018 | Issued |
Array
(
[id] => 17059006
[patent_doc_number] => 11103588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Methods and compositions relating to carnitine-derived materials
[patent_app_type] => utility
[patent_app_number] => 16/619806
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 17886
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619806 | Methods and compositions relating to carnitine-derived materials | Jun 5, 2018 | Issued |
Array
(
[id] => 16152127
[patent_doc_number] => 20200214296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => MICROBICIDAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/621762
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621762 | MICROBICIDAL COMPOSITION | Jun 5, 2018 | Abandoned |
Array
(
[id] => 13574789
[patent_doc_number] => 20180338943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/994493
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994493
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994493 | POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS | May 30, 2018 | Abandoned |
Array
(
[id] => 13440547
[patent_doc_number] => 20180271816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and Related Compounds as GABA Aminotransferase Inactivators for the Treatment of Epilepsy, Addiction and Hepatocellular Carcinoma
[patent_app_type] => utility
[patent_app_number] => 15/991323
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/991323 | (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and Related Compounds as GABA Aminotransferase Inactivators for the Treatment of Epilepsy, Addiction and Hepatocellular Carcinoma | May 28, 2018 | Abandoned |
Array
(
[id] => 16569047
[patent_doc_number] => 20210008053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMBINATION THERAPIES FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/614131
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614131 | Combination therapies for treating cancer | May 17, 2018 | Issued |
Array
(
[id] => 14273217
[patent_doc_number] => 20190133893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Tooth Paste Gummy
[patent_app_type] => utility
[patent_app_number] => 15/982069
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982069 | Tooth Paste Gummy | May 16, 2018 | Abandoned |
Array
(
[id] => 16612083
[patent_doc_number] => 20210030736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => USE OF EZH2 INHIBITOR COMBINED WITH BTK INHIBITOR IN PREPARING DRUG FOR TREATING TUMOR
[patent_app_type] => utility
[patent_app_number] => 16/611969
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611969 | Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor | May 16, 2018 | Issued |
Array
(
[id] => 13413059
[patent_doc_number] => 20180258072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => QUINOLINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 15/975999
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975999
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975999 | Quinoline derivative | May 9, 2018 | Issued |
Array
(
[id] => 14087959
[patent_doc_number] => 10239870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Dopamine D3 receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 15/975466
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61946
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975466 | Dopamine D3 receptor antagonists | May 8, 2018 | Issued |
Array
(
[id] => 15963787
[patent_doc_number] => 20200165645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => PROCESS FOR PRODUCING AN AZAPHILONE IN TALAROMYCES ATROROSEUS
[patent_app_type] => utility
[patent_app_number] => 16/611066
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611066
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611066 | Process for producing an azaphilone in | May 7, 2018 | Issued |
Array
(
[id] => 14791351
[patent_doc_number] => 10398660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Imaging composition and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/963599
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 48
[patent_no_of_words] => 10926
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15963599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/963599 | Imaging composition and uses thereof | Apr 25, 2018 | Issued |